{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:06:13Z","timestamp":1784279173546,"version":"3.55.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijrobp.2026.02.225","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:10:21Z","timestamp":1784099421000},"page":"1466-1470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Prostate-Specific Antigen and Conventional Imaging: How Prostate-Specific Membrane Antigen Positron Emission Tomography Is Transforming Postradiation Therapy Monitoring in Oligometastatic Prostate Cancer"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-3460","authenticated-orcid":false,"given":"Salvatore","family":"Cozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Brenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Vial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Roukoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela E.","family":"Oprea-Lager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9883","authenticated-orcid":false,"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.02.225_bib0001","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2026.02.225_bib0002","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00066-017-1239-1","article-title":"Oligometastases in prostate cancer: Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT","volume":"194","author":"Baumann","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2026.02.225_bib0003","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1148\/radiol.2016142043","article-title":"Practical PERCIST: A simplified guide to PET response criteria in solid tumors 1.0","volume":"280","author":"O","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2026.02.225_bib0004","first-page":"528","article-title":"PSMA PET\/CT to evaluate response to SBRT for prostate cancer bone metastases","volume":"26","author":"Sadetski","year":"2021","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2026.02.225_bib0005","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s12094-022-03002-7","article-title":"Metabolic response after 68Ga-PSMA-PET\/CT-directed IGRT\/SBRT for oligometastases prostate cancer","volume":"25","author":"Gawish","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.225_bib0006","article-title":"Prostate-specific membrane antigen PET response associates with metastasis-free survival after stereotactic ablative radiation in oligometastatic prostate cancer","volume":"9","author":"Sutera","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.02.225_bib0007","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41824-024-00212-w","article-title":"PSMA-PET\/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancer","volume":"8","author":"Sheikh","year":"2024","journal-title":"EJNMMI Rep"},{"key":"10.1016\/j.ijrobp.2026.02.225_bib0008","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00259-020-04934-4","article-title":"Consensus statements on PSMA PET\/CT response assessment criteria in prostate cancer","volume":"48","author":"Fanti","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2026.02.225_bib0009","article-title":"PSMA response evaluation in follow-up PSMA-PET\/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer","volume":"54","author":"Zang","year":"2025","journal-title":"Clin Transl Radiat Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ijrobp.2026.02.225_bib0010","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2026.02.225_bib0011","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.ijrobp.2025.06.3858","article-title":"Gallium-68-labeled prostate-specific membrane antigen positron emission tomography\/computed tomography response in pelvic node-positive prostate cancer after definitive radiation therapy: Prognostic implications","volume":"123","author":"Onal","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.02.225_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41391-025-01056-6","article-title":"Progression of index metastases in oligometastatic hormone-sensitive prostate cancer: Implications for metastases directed therapy?","author":"Verma","year":"2025","journal-title":"Prostate Cancer Prostatic Dis."}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626004050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T08:25:57Z","timestamp":1784276757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626004050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0360301626004050"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.225","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond Prostate-Specific Antigen and Conventional Imaging: How Prostate-Specific Membrane Antigen Positron Emission Tomography Is Transforming Postradiation Therapy Monitoring in Oligometastatic Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.02.225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}